Ignored and undervalued in public health: a systematic review of health state utility values associated with syphilis infection

• Published in: Health and quality of life outcomes 2024-02, Vol.22 (1), p.17-21, Article 17
• Main Authors: Miao, Patrick, Terris-Prestholt, Fern, Fairley, Christopher K, Tucker, Joseph D, Wiseman, Virginia, Mayaud, Philippe, Zhang, Ying, Rowley, Jane, Gottlieb, Sami, Korenromp, Eline L, Watts, Caroline G, Ong, Jason J
• Format: Article
• Language: English
• Subjects: Birth weight; Complications and side effects; Congenital diseases; Cost analysis; Disability; Disability weight; Disease; Economic aspects; Epidemiology; Health disparities; Health economics; Health state utility value; HIV; Human immunodeficiency virus; Industrialized nations; Infections; Medical economics; Medical research; Medicine, Experimental; Morbidity; Mortality; Policy making; Portrayals; Prevention; Public health; Quality of life; Review; Sexually transmitted diseases; STD; Stillbirth; Syphilis; Systematic review; Utility weight
• ISSN: 1477-7525; 1477-7525
• DOI: 10.1186/s12955-024-02234-1

Syphilis is a sexually transmitted infection causing significant global morbidity and mortality. To inform policymaking and economic evaluation studies for syphilis, we summarised utility and disability weights for health states associated with syphilis. We conducted a systematic review, searching six databases for economic evaluations and primary valuation studies related to syphilis from January 2000 to February 2022. We extracted health state utility values or disability weights, including identification of how these were derived. The study was registered in the international prospective register of systematic reviews (PROSPERO, CRD42021230035). Of 3401 studies screened, 22 economic evaluations, two primary studies providing condition-specific measures, and 13 burden of disease studies were included. Fifteen economic evaluations reported outcomes as disability-adjusted life years (DALYs) and seven reported quality-adjusted life years (QALYs). Fourteen of 15 economic evaluations that used DALYS based their values on the original Global Burden of Disease (GBD) study from 1990 (published in 1996). For the seven QALY-related economic evaluations, the methodology varied between studies, with some studies using assumptions and others creating utility weights or converting them from disability weights. We found a limited evidence base for the valuation of health states for syphilis, a lack of transparency for the development of existing health state utility values, and inconsistencies in the application of these values to estimate DALYs and QALYs. Further research is required to expand the evidence base so that policymakers can access accurate and well-informed economic evaluations to allocate resources to address syphilis and implement syphilis programs that are cost-effective.